Type 2 herpes, also called HSV-2, is a viral infection that causes genital herpes. It spreads through sexual contact and stays in the body permanently, living dormant in nerve cells near the base of the spine and reactivating periodically to cause outbreaks of painful blisters. About 12% of Americans between ages 14 and 49 carry the virus, and many don’t know it because symptoms can be mild or absent entirely.
How HSV-2 Differs From HSV-1
There are two types of herpes simplex virus. HSV-1 traditionally causes oral herpes (cold sores), while HSV-2 is the primary cause of genital herpes. The key difference comes down to where each virus prefers to set up camp. After the initial infection, HSV-1 embeds itself in a cluster of nerve cells near the head and face, which is why it tends to affect the mouth and upper body. HSV-2 settles into nerve cells called the sacral ganglia at the base of the spine, making it more likely to cause sores in the genital area, buttocks, and thighs.
This matters for more than just location. HSV-2 is significantly more aggressive in the genital region than HSV-1. It recurs more often, sheds the virus more frequently (even when no sores are visible), and continues shedding at high rates years after the first infection. HSV-1 genital infections, by contrast, tend to quiet down relatively quickly. Untreated people with genital HSV-2 may experience anywhere from one to twelve outbreaks per year.
What an Outbreak Feels Like
The first outbreak is almost always the worst. Many people notice a tingling or burning sensation in the genital area before any sores appear. This warning phase, called the prodrome, may also include itching and discomfort during urination. Within a day or two, a cluster of small blisters or open sores develops. These lesions burn, can be quite painful, and typically show up on the vulva, vagina, penis, scrotum, buttocks, anus, or thighs.
A first episode often comes with whole-body symptoms too: fever, headache, joint pain, and general fatigue. The blisters crust over and heal without scarring, but the entire first outbreak can last two to three weeks. Future flare-ups are generally shorter, less painful, and involve fewer sores. Over time, most people find that outbreaks become less frequent, though the pattern varies widely from person to person.
Transmission and Viral Shedding
HSV-2 spreads through direct skin-to-skin contact during vaginal, anal, or oral sex. The virus is most contagious when sores are present, but it also transmits during “viral shedding,” periods when the virus is active on the skin’s surface with no visible symptoms at all. This asymptomatic shedding is actually how most new infections happen, because people are unlikely to have sex during an obvious outbreak.
Consistent condom use cuts the risk roughly in half. In one large study, 8% of people who never used condoms acquired HSV-2, compared to 4.6% of those who used them more than 75% of the time. Condoms don’t eliminate risk entirely because the virus can shed from skin that a condom doesn’t cover.
How Common It Is
HSV-2 prevalence rises steadily with age. Among 14- to 19-year-olds in the U.S., less than 1% test positive. That climbs to about 7.6% in people in their twenties, 13.3% in their thirties, and 21.2% in their forties. By middle age, roughly one in five people carries the virus. Many of them were never diagnosed because they either had no symptoms or mistook mild outbreaks for something else.
Testing and Diagnosis
If you have active sores, a healthcare provider can swab the lesion and test for viral DNA directly. This is the most reliable method during an outbreak. When no sores are present, a blood test looks for antibodies your immune system has built against HSV-2. The catch is timing: if you’ve been recently exposed, your body may not have produced enough antibodies yet, leading to a false negative. The CDC notes that testing too soon after infection increases the chance of an inaccurate result, so waiting several weeks after potential exposure improves reliability.
False positives are also a concern with blood tests. The FDA has warned that certain HSV-2 antibody tests can produce falsely reactive results, particularly when the antibody index falls in a low-positive range. If your result is unexpected or doesn’t match your symptoms, a confirmatory test is worth requesting.
Treatment Options
There’s no cure for HSV-2, but antiviral medications make a significant difference in outbreak severity, frequency, and transmission risk. Treatment falls into two categories.
Episodic therapy means taking antivirals at the first sign of an outbreak (ideally during that tingling prodrome phase) and continuing for two to five days. This shortens the outbreak and reduces its severity. It works best when you start the medication within the first 24 hours of symptoms.
Suppressive therapy means taking a low dose of antiviral medication every day, whether or not you’re having symptoms. This approach reduces outbreaks by a large margin and also lowers the amount of viral shedding, which decreases the chance of passing the virus to a partner. People who have frequent outbreaks or who want to minimize transmission risk to a partner often choose this route. The most commonly prescribed antivirals for HSV-2 are acyclovir, valacyclovir, and famciclovir.
Pregnancy and HSV-2
The main concern during pregnancy is neonatal herpes, a rare but serious condition that occurs when the virus passes to the baby during delivery. The risk depends heavily on when the mother acquired the infection. Women who catch HSV-2 for the first time late in pregnancy pose the highest risk because their bodies haven’t yet developed the antibodies that help protect the baby. In a University of Washington study, the highest transmission rate, about 1 in 1,900 deliveries, was among women whose blood showed no HSV antibodies, meaning they were newly infected.
Women who’ve carried HSV-2 for longer have much lower risk. Their transmission rate was roughly 2 in 5,761 births, because existing antibodies cross the placenta and offer the baby some protection. When active lesions are present at the time of delivery, a cesarean section is typically recommended to avoid direct contact with the virus.
HSV-2 and HIV Risk
Having HSV-2 increases the risk of acquiring HIV by two- to threefold. The open sores create a direct entry point for the virus, and even without visible sores, the immune cells that HSV-2 attracts to the genital area are the same cells HIV targets. This connection makes HSV-2 management especially important for people at higher risk of HIV exposure.
Living With HSV-2
For most people, HSV-2 becomes a manageable condition rather than a defining one. Outbreaks tend to decrease in both frequency and severity over the years. Daily suppressive therapy can reduce outbreaks to near zero for many people and significantly lowers transmission risk to partners. Using condoms, avoiding sex during active outbreaks, and communicating with partners about status are the practical cornerstones of reducing spread.
The emotional impact of a diagnosis often hits harder than the physical symptoms. Stigma around genital herpes tends to be disproportionate to the actual medical significance of the virus, especially considering that more than one in ten adults carry it and most experience only mild or infrequent symptoms.